Antibiotic Resistance: Page 3

Day Zero Diagnostics closes $21M funding round

By LabPulse.com staff writers

The company is developing sequencing-based diagnostic technologies that can identify both the species and the antibiotic-resistance profile of a bacterial pathogen within hours.

February 10, 2022

Hologic launches on-demand molecular testing in Europe

By LabPulse.com staff writers

Novodiag features real-time polymerase chain reaction and microarray capabilities that allow for multiple pathogens to be identified from a single sample, Hologic said. Its CE-marked IVD test menu includes assays for gastrointestinal infection, antibiotic resistance, and SARS-CoV-2.

October 5, 2021

DNA testing speeds pneumonia diagnoses in COVID-19 patients

By LabPulse.com staff writers

Developed at Addenbrooke's Hospital in Cambridge, U.K., with Public Health England, the polymerase chain reaction (PCR) test screens for 52 different pathogens that may cause respiratory illness in intensive care patients.

January 14, 2021

Bruker launches microbe test kit following FDA clearance

By LabPulse.com staff writers

Rapid sepsityper identification is crucial for the care of critically ill patients in order to reduce turnaround time for disease-specific treatment, noted Dr. Wolfgang Pusch, executive vice president of microbiology and diagnostics at Bruker. The new test kit can identify microbial species once a blood culture system has detected growth, but it does not test for resistance of antibiotic susceptibility.

January 3, 2021

Firm developing rapid gonorrhea test wins $19M prize

By LabPulse.com staff writers

Visby Medical won the prize for its patient-side, disposable, molecular polymerase chain reaction (PCR) diagnostic device that detects Neisseria gonorrhoeae as well as markers of drug resistance. The device is a palm-sized, single-use, disposable device that detects N. gonorrhoeae and can determine whether the bacteria is susceptible to a single-dose antibiotic.

August 5, 2020

LexaGene to unveil rapid multipathogen genetic test this fall

By LabPulse.com staff writers

The product, which is currently being manufactured, aims to deliver reference-quality molecular testing data at the point of care. It screens samples for up to 27 different targets at once, looking for pathogens and antimicrobial resistance factors. Results are delivered in about an hour, according to the company.

July 14, 2020

Inflammatix gets $32M infusion for HostDx rapid POC tests

By LabPulse.com staff writers

Based in Burlingame, CA, Inflammatix is developing blood and nasal swab tests for the detection of infections and antibiotic resistance. Its platform is informed by machine-learning algorithms and gene expression patterns to identify bacterial and viral infections, and it yields results in 30 minutes or less, according to the company.

January 9, 2020

Curetis plans Q1 U.S. launch for Unyvero pneumonia test

By LabPulse.com staff writers

Designed for use with the company's Unyvero system, the LRT bronchoalveolar panel screens for pneumonia and other respiratory infections. It detects a broad range of causes of infections, including atypical pathogens, such as the fungus Pneumocystitis jirovecii, and screens for antibiotic resistance markers, which is helpful for guiding treatment decisions, according to the company.

December 22, 2019

MicroRNAs predict problems in pneumonia patients

By LabPulse.com staff writers

Identifying particular microRNAs -- small molecules involved in the regulation of gene expression -- using polymerase chain reaction (PCR) testing at the time patients are hospitalized with severe pneumonia could alert health professionals to risks and help prevent complications, reported Dr. Francisco Sanz, a pulmonologist at Consorci Hospital General Universitari de València, and colleagues. Testing is affordable, is readily available in hospitals, and takes from one to three hours, the researchers noted.

October 2, 2019

SpeeDx Mgen STI test debuts in Europe

By LabPulse.com staff writers

The diagnostic test screens for Mgen as well as for resistance to the macrolide class of antibiotics, such as azithromycin, which is a first-line treatment for the infection. Cepheid will be responsible for marketing and distributing the Mgen test for use with its Flexible cartridge and GeneXpert system.

September 5, 2019

Urine tests at root of antibiotic misuse in Blue Cross study

By Emily Hayes

For the study, researchers retrospectively evaluated the records of 2,733 hospitalized patients with asymptomatic bacteriuria in 46 Michigan hospitals. They examined how many patients received antibiotics after an abnormal urinalysis result, along with a range of clinical outcomes, including mortality, readmission rates, and emergency room visits. The group also looked at how long patients were hospitalized after a urine test.

August 27, 2019

iCubate's iC-GN Gram-negative assay clears FDA

By LabPulse.com staff writers

Bacteria picked up by the iC-GN test include Acinetobacter baumannii complex, Escherichia coli, and Klebsiella pneumoniae, while the antibiotic resistance markers screened by the test include K. pneumoniae carbapenemase (KPC) and New Delhi metallo-beta-lactamase (NDM). Testing takes from two to three minutes, with results available in from 3 to 4.5 hours, according to the company.

July 14, 2019

Previous Page

Page 3 of 4

Next Page